tm logo
LIFCASUS
Live/Pending
PUBLICATION/ISSUE REVIEW COMPLETE

on 01 Jan 2025

Last Applicant/ Owned by

Route 206 & Province Line Road

Princeton

NJ

08543

Serial Number

98397734 filed on 08th Feb 2024

Registration Number

N/A

Correspondent Address

Marilyn F. Kelly

Marilyn F. Kelly Bristol-Myers Squibb Company

Trademark Dept., Mailstop D. 4243

Princeton, NJ 08648-4000

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

LIFCASUS

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprol Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical and biological preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use; Pharmaceutical preparations for human use, namely, for the treatment of neuropsychiatric disorders; Pharmaceutical preparations for human use, namely, therapeutic radiopharmaceutical preparations for the treatment of cancer and solid tumors, diagnostic radiopharmaceutical preparations, diagnostic agents, preparations and substances for medical purposes; Pharmaceutical preparations for human use, namely, radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer, radio-isotope markers for therapeutic or diagnostic use.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98397734

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 00163219-US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
30th Dec 2024APPROVED FOR PUB - PRINCIPAL REGISTER
03rd Dec 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
03rd Dec 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
03rd Dec 2024TEAS/EMAIL CORRESPONDENCE ENTERED
03rd Sep 2024NON-FINAL ACTION E-MAILED
03rd Sep 2024NON-FINAL ACTION WRITTEN
03rd Sep 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
28th Aug 2024ASSIGNED TO EXAMINER
07th Jun 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08th Feb 2024NEW APPLICATION ENTERED